Atara Biotherapeutics (ATRA) Reports Q3 Loss of $4.20

Atara Biotherapeutics (NASDAQ: ATRA) reported Q3 EPS of ($4.20), versus ($2.59) reported last year.

For earnings history and earnings-related data on Atara Biotherapeutics (ATRA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Notice to Long-Term Shareholders of Badger Meter, Inc. (NYSE: BMI); GeneDx Holdings Corp. (NASDAQ: WGS); GRAIL, Inc. (NASDAQ: GRAL); and Verra Mobility Corporation (NASDAQ: VRRM): Grabar Law Office i
• In HelloNation, Wealth Advisor Matt Cuplin Explains How Taxes Affect Retirement Income